MyFinsight
Home
Compare
Blog
About
Proceeds from issuance of
series a redeemable...
$59,596K
Net cash provided by
financing activities
$58,834K
Canceled cashflow
$762K
Net increase in cash
and cash...
$33,670K
Canceled cashflow
$25,164K
Payments for deferred
offering costs
$762K
Accrued expenses and
other current...
$3,912K
Stock-based compensation
$2,846K
Accounts payable
$936K
Depreciation and
amortization
$5K
Net cash used in
operating activities
-$22,136K
Net cash used in
investing activities
-$3,028K
Canceled cashflow
$7,699K
Net loss
-$29,268K
Cash paid for
purchased in-process...
$3,000K
Purchase of property and
equipment
$28K
Prepaid expenses and
other current assets
$462K
Operating lease
right-of-use asset and lease...
$105K
Back
Back
Cash Flow
Braveheart Bio, Inc. (BRVE)
Braveheart Bio, Inc. (BRVE)
source: myfinsight.com